SUPRIYA
NSESupriya Lifescience Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹854.60
20.30 (2.32%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹6.88K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
33.7
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹545.5+56.7%
52W High₹1,085-21.2%
Current Price
₹854.60
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹683.68
Upper Circuit₹1,025.52
Reference Price
₹854.60
Investment Checklist
Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹888.4
Double Bottom on 1W (BREAKOUT CONFIRMED) — target ₹963.55
Volume divergence: Bullish (price down, volume up)
10/20 Bearish Cross detected 3 day(s) ago
EMA(50) Crossover: Price crossed below EMA(50): Fresh bearish weakness signal.
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
41%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)
EMA20
911.59
EMA50
858.44
EMA200
756.53
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows3
Lower Highs6
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹906.50
₹1010.00
₹1043.20
₹1085.00
Support (Below)
₹832.40
₹823.25
₹768.50
₹751.73
₹735.35
Volume Analysis
TrendINCREASING
Change+107.00%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Recent MA Crossovers
10/20 Bearish Cross
3 days ago
SELL
Recent Price Gaps
Gap Down
5 days ago • 1.96%
BEARISH
Stop Loss Levels
Fixed Risk
1% Risk₹846.05
3% Risk₹828.96
5% Risk₹811.87
7% Risk (Custom)
₹794.78Technical Levels
1x ATR (Volatility)₹804.08
2x ATR (Swing)₹753.56
3x ATR (Trend)₹703.04
Immediate Support₹832.40
Moving Averages
EMA 200 (Long-term)₹756.53
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹167.2 Cr | ₹145.1 Cr | ₹199.8 Cr | ₹206.4 Cr |
| Net Profit | ₹50.4 Cr | ₹34.8 Cr | ₹50.4 Cr | ₹49.7 Cr |
| EPS | — | ₹4.32 | ₹6.27 | ₹6.17 |
| Operating Profit | ₹69.4 Cr | ₹54.4 Cr | ₹75.4 Cr | ₹74.2 Cr |
ROE
18.86%
ROCE
24.84%
Debt/Equity
0.01
Current Ratio
5.32
OPM
35.96%
NPM
24.06%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Supriya Lifescience Limited | ₹854.60 | -2.32% | 33.7 | ₹6.88K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 04 Sept 2025 | Dividend - Re 1 Per Share | DIVIDEND |
| 20 Sept 2024 | Annual General Meeting/Dividend - Rs 0.80 Per Share | AGM |
| 15 Sept 2023 | Annual General Meeting/Dividend - Re 0.60 Per Share | AGM |
| 01 Sept 2022 | Annual General Meeting/Dividend - Re 0.60 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SUPRIYA
View AllNEWS
negative
Business Standard - Markets 4d ago
Supriya Lifescience Ltd leads losers in 'A' group
PC Jeweller Ltd, Zensar Technologies Ltd, Ola Electric Mobility Ltd and Apollo Micro Systems Ltd are among the other losers in the BSE's 'A' group today, 06 July 2026.
APOLLOBSEOLAELECPCJEWELLERRSYSTEMSSUPRIYAZENSARTECHAutomobile and Auto ComponentsCapital Goods
negative
Business Standard - Markets 4d ago
Supriya Lifescience tanks 12%; why pharma stock under pressure?
Supriya Lifescience said proceedings were initiated against the personnel of the company under the NDPS Act, 1985 for a procedural lapse for a single export transaction of an identified producer.
SUPRIYAHealthcare
neutral
Business Standard - Markets 4d ago
Supriya Lifescience tanks 12%; what's ailing this pharma stock?
Supriya Lifescience said proceedings were initiated against the personnel of the company under the NDPS Act, 1985 for a procedural lapse for a single export transaction of an identified producer.
SUPRIYAHealthcare